查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854800

近距離放射治療設備市場（依產品類型、應用、放射源類型及最終用戶分類）－2025-2032年全球預測

Brachytherapy Devices Market by Product Type, Application, Source Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，近距離放射治療設備市場規模將達到 40.3 億美元，複合年成長率為 13.99%。

關鍵市場統計數據
基準年 2024 14.1億美元
預計年份：2025年 16億美元
預測年份 2032 40.3億美元
複合年成長率 (%) 13.99%

本文概述了近距離放射治療設備在當代腫瘤治療中不斷演變的作用、臨床需求、創新促進因素以及相關人員的決策重點。

近距離放射治療設備仍然是精準放射治療的基石，它將局部劑量傳遞與優先考慮器官保護和功能預後的臨床通訊協定相結合。目前的技術格局涵蓋了成熟的密封源治療和不斷演進的輸送系統，這些系統旨在降低手術複雜性並提高劑量適形性。臨床醫生、醫院管理者和技術投資者正在評估這些治療方法，並將其與競爭性的外照射療法、患者吞吐量壓力以及支持多學科腫瘤團隊的整合式診療路徑的需求進行比較。

本導言概述了構成當前策略環境的關鍵臨床促進因素和創新方向。它重點闡述了設備人體工學、施用器設計、源處理物流以及相關數位化解決方案如何影響醫院的採購週期和臨床應用決策。後續分析圍繞著臨床有效性、安全通訊協定和營運整合展開，將技術趨勢與相關人員為保持競爭力和臨床相關性而必須考慮的實際問題連結起來。

找出將透過技術融合、臨床工作流程整合和政策主導的必要措施重塑近距離放射治療設備格局的變革性轉變。

近距離放射治療領域正受到多種因素的共同影響而再形成，這些因素共同改變了臨床工作流程和商業模式。技術融合尤為顯著。影像導引定位、模組化施源器以及改進的治療計畫軟體，使得放射源定位更加精準，治療計畫更具適應性，從而降低了不同腫瘤部位的治療差異，並擴大了合格。同時，工作流程自動化和混合手術室的出現，減輕了手術室和介入團隊的手術負擔，使當日或門診治療模式成為可能。

不斷變化的法規和對輻射安全日益成長的關注促使製造商投資於密封源管理和方便用戶使用的屏蔽解決方案，而支付方則越來越重視基於價值的治療結果，將手術選擇與患者報告的指標和長期毒性特徵聯繫起來。同時，供應鏈的韌性和零件採購的在地化也變得日益重要，推動了雙重採購和區域製造夥伴關係等策略的發展。設備設計的進步影響著治療路徑的整合，監管重點推動設計檢驗，而報銷框架則影響哪些創新能夠規模化應用。

評估美國於 2025 年實施關稅對近距離放射治療設備供應鏈、臨床進入途徑和採購彈性策略的累積影響

2025年即將生效的醫療設備組件和放射源關稅的實施，為製造商、醫療服務提供者和經銷商帶來了新的營運和策略挑戰。採購團隊正在重新評估供應商關係、前置作業時間緩衝和庫存策略，以應對潛在的成本波動，同時確保醫療服務的連續性。因應措施包括重新談判長期供應合約、調整物流路線，以及與區域供應商更緊密合作，以減輕跨境成本調整的影響。

在臨床方面，醫院和專科癌症中心正在實施庫存管理和優先排序通訊協定，以確保高風險病例能夠及時獲得所需資源。製造商正在加快對替代組件供應商進行資格認證，並檢驗不同製造地的等效性，以便在不影響品質保證流程的前提下調整生產。同時，商業團隊正在調整合約方式和服務組合，以維持客戶的整體醫療提案，並強調提供整合的培訓、維護和供應商管理支持，從而在主導不確定性中保持臨床合作夥伴的信心。

結合產品類型、臨床應用、放射源類型和最終用戶環境等關鍵細分因素，為制定有針對性的臨床和商業策略提供資訊。

以市場區隔主導的觀點揭示了不同的動態，從而為產品開發和上市決策提供基礎。以產品類型（高劑量率、低劑量率、脈衝劑量率）評估，高劑量率系統因其操作高效且適用於多種臨床適應症而持續吸引投資。脈衝劑量率則佔據獨特的市場定位，適用於放射生物學原理和患者個體化因素更傾向於間歇性劑量傳遞的場合。

在乳癌、子宮頸癌、眼部腫瘤和攝護腺癌等臨床應用進行細分後發現，臨床證據、指引核准和多專業團隊的採納是推動市場需求的主要因素。例如，前列腺癌的治療流程通常需要整合影像技術和高精度施源器，而眼科治療則優先考慮微源處理和專用準直器。放射源類型（Cs-137、I-125、Ir-192 和 Pd-103）的差異會影響處理、半衰期物流、監管核准和劑量計畫。對最終用戶（包括門診手術中心、癌症研究中心和醫院）的細分錶明，不同的採購模式和營運限制各不相同。門診手術中心尋求緊湊、高效且支援高通量的系統；研究中心優先考慮模組化設計和用於臨床實驗方案的檢測功能；而醫院則需要完善的服務協議以及與現有放射治療設備的整合。這種細分有助於制定產品藍圖、臨床培訓投資和商業性提案主張，從而確保產品與特定使用者需求和流程基礎設施保持一致。

美洲、歐洲、中東和非洲以及亞太地區的區域優先事項和差異化成長促進因素將影響臨床應用和採購動態。

區域動態持續決定著各地區的採納速度和部署策略。在美洲，先進的臨床基礎設施和完善的報銷機制促進了迭代式醫療器材創新技術的早期應用，而成本控制壓力和採購週期則要求企業提供令人信服的整體醫療成本分析。歐洲、中東和非洲的情況則較為複雜，協調一致的監管環境、區域採購聯盟以及多樣化的臨床能力塑造了差異化的參與策略策略。亞太地區的特點是三級癌症治療中心的容量快速擴張、微創手術的積極推廣以及本地製造能力的不斷提升，這些因素共同構成了國際開發商面臨的競爭挑戰和合作開發機會。

每個地區在培訓、監管申報和上市後監測方面都需要採取細緻入微的方法。相關人員必須考慮到臨床指南、操作人員技能水平和設施佈局的差異，製造商應優先考慮可自訂的模組化解決方案，以滿足當地的流程和基礎設施要求。與區域臨床領導者建立策略夥伴關係，並投資於可擴展的培訓項目，對於將最初的興趣轉化為這些不同市場中一致的臨床應用至關重要。

深入了解與領先製造商和創新者的合作關係、智慧財產權定位以及塑造該行業動態的服務導向提案，從而獲得競爭和企業層面的洞察。

近距離放射治療領域的競爭格局呈現出傳統製造商、新興設備創新者和專業服務供應商三者融合的趨勢。現有企業憑藉完善的服務網路、良好的監管記錄以及包含施源器、放射源和計劃軟體的整合產品組合來脫穎而出。新參與企業則試圖透過在使用者人體工學、放射源輸送機制以及雲端治療計畫等方面進行創新來取代現有企業，從而降低現場運算需求。

策略性企業行動包括與影像和腫瘤軟體供應商建立合作關係，以提供端到端的治療路徑；投資於施用器形狀和源封裝相關的智慧財產權；以及拓展附加價值服務，例如遠端培訓、維護即服務和庫存管理。觀察到的商業性策略專注於與領先的臨床中心開展概念概念驗證項目，以加速產生同行評審的證據；此外，還採用分級定價模式，以反映終端用戶的異質性，涵蓋從高流量門診手術中心到複雜的三級醫院。這些策略共同塑造了公司的競爭定位，並影響與醫療系統採購委員會的採購談判。

為行業領導者提供可操作的建議，以使其研發、商業模式、供應鏈韌性和相關人員參與與不斷變化的臨床和政策要求保持一致。

產業領導者應優先考慮舉措。這些舉措包括影像整合、應用器模組化以及簡化的來源處理流程，從而縮短手術時間並減少手術差異。其次，企業應制定穩健的供應鏈多元化計劃，包括可行的替代供應商和區域生產方案，以降低關稅和物流波動的影響，並為醫療服務提供者合作夥伴提供透明的庫存管治工具。

第三，商業策略應強調捆綁銷售，並提供培訓、維護和供應商管理等服務，以確保客戶生命週期經濟效益的可預測性。第四，與領先的臨床中心建立正式夥伴關係，推動積極證據的產生和指南的採納，有助於建立持續的臨床偏好。最後，積極與監管機構和支付方溝通，闡明安全性、有效性和價值提案，可以促進產品推廣，並使報銷結構與患者和醫療系統的長期利益保持一致。實施這些建議需要跨部門的共同努力，以及與臨床應用和服務績效相關的可衡量的關鍵績效指標 (KPI)。

透明的調查方法，詳細說明資料來源、定性和定量分析方法、相關人員訪談以及檢驗步驟，以確保研究的嚴謹性和可重複性。

本摘要的分析基於以下幾個方面：與關鍵相關人員的溝通、技術文獻的綜合分析，以及對公開的監管和臨床指南文件的三角比較。主要資訊來源包括與放射腫瘤科醫師、醫學物理學家、採購負責人和臨床工程師的結構化訪談，旨在檢驗實際工作流程、設備操作痛點和採購理由。次要資訊來源則著重於同儕審查的臨床結果文獻、設備安全通告和操作指南，以將設備特性與臨床適應症相匹配。

分析技術包括交叉細分綜合分析，用於識別產品屬性與臨床應用案例之間的契合度；情境分析，用於探索供應鏈衝擊和關稅的影響；以及對競爭性提案主張進行定性基準分析。檢驗步驟包括與臨床醫生和生物醫學工程師進行專家評審，以確認建議的技術準確性和適用性。在條件允許的情況下，所有論點均由多個獨立資訊來源提供支持，以確保其穩健性和對臨床、採購和企業策略等各領域決策者的相關性。

簡明扼要的結論，整合了策略意義、營運風險以及對臨床、商業和監管相關人員的優先機會。

總之，近距離放射治療設備在腫瘤治療領域佔有策略性地位，兼具精準性、器官保留和手術效率。輸送系統的技術進步、不斷變化的監管預期以及支付方對基於價值的治療結果的重視，共同為設備開發商和臨床應用者帶來了機會和挑戰。供應鏈壓力和關稅導致的成本動態變化需要積極的應對策略，而區域性的培訓和服務提供方式將決定不同醫療保健系統應用的速度和品質。

成功整合臨床證據產生、模組化產品設計和穩健商業模式的相關人員，更有可能贏得長期的臨床夥伴關係。透過強調與現有腫瘤工作流程的互通性、強化以用戶為中心的設計，以及投資於與領先臨床中心開展的合作證據項目，各機構可以將創新轉化為可衡量的臨床和營運價值。未來的發展方向是優先考慮既能解決日常操作難題，又能推進長期治療目標的實用性創新。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將磁振造影和超音波即時影像整合用於近距離放射治療治療計劃和實施
  • 使用 3D 列印的患者專用近距離放射治療施用器可以提高劑量一致性並減少設定時間。
  • 開發新型低劑量率同位素，例如銫-131，以加速放射性崩壞並改善患者預後。
  • 人工智慧驅動的治療計畫軟體應運而生，能夠實現精準的種子植入並降低手術風險。
  • 新興市場對磁振造影引導近距離近距離放射治療的日益普及，得益於有利的報銷政策。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按產品類型分類的近距離放射治療設備市場

  • 高劑量率
  • 低劑量率
  • 脈衝劑量率

第9章 按應用分類的近距離放射治療設備市場

  • 乳癌
  • 子宮頸癌
  • 眼部腫瘤
  • 攝護腺癌

第10章 依來源類型分類的近距離放射治療設備市場

  • 銫-137
  • I-125
  • 銥-192
  • Pd-103

第11章 按最終用戶分類的近距離放射治療設備市場

  • 門診手術中心
  • 癌症研究中心
  • 醫院

第12章 各地區近距離放射治療設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 近距離放射治療設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國近距離放射治療設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Varian Medical Systems, Inc.
    • Elekta AB（publ）
    • Ion Beam Applications SA
    • CR Bard, Inc.
    • Eckert & Ziegler AG
    • Theragenics Corporation
    • IsoRay, Inc.
    • Proxima Therapeutics, Inc.
    • Shanghai Atom High-Tech Co., Ltd.
    • Best Medical International, Inc.
Product Code: MRR-957C47F94A6F

The Brachytherapy Devices Market is projected to grow by USD 4.03 billion at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.41 billion
Estimated Year [2025] USD 1.60 billion
Forecast Year [2032] USD 4.03 billion
CAGR (%) 13.99%

Framing the evolving role of brachytherapy devices in contemporary oncology care, outlining clinical imperatives, innovation drivers, and stakeholder decision priorities

Brachytherapy devices remain a cornerstone of precision radiotherapy, combining localized dose delivery with clinical protocols that prioritize organ preservation and functional outcomes. The technology landscape now spans established sealed-source treatments and evolving delivery systems that seek to reduce procedural complexity while improving dosimetric conformity. Clinicians, hospital administrators, and technology investors are evaluating these modalities against competing external-beam approaches, patient throughput pressures, and the need for integrated care pathways that support multidisciplinary oncology teams.

This introduction outlines the principal clinical drivers and innovation vectors that define the current strategic environment. Emphasis is given to how device ergonomics, applicator design, source handling logistics, and adjacent digital solutions are informing hospital procurement cycles and clinical adoption decisions. By framing the discussion around clinical efficacy, safety protocols, and operational integration, the subsequent analysis will connect technological trends with pragmatic considerations that stakeholders must address to maintain competitive and clinical relevance.

Identifying transformative shifts reshaping the brachytherapy device landscape through technology convergence, clinical workflow integration, and policy-driven imperatives

The brachytherapy landscape is being reshaped by several converging forces that collectively alter clinical workflows and commercial models. Technological convergence is prominent: improvements in imaging-guided placement, applicator modularity, and treatment planning software are enabling more precise source positioning and adaptive planning, thereby reducing variability and broadening eligibility across tumor sites. At the same time, workflow automation and hybrid procedural suites are lowering the procedural burden on operating rooms and interventional teams, which makes same-day or ambulatory delivery models more feasible.

Regulatory evolution and heightened attention to radiation safety have prompted manufacturers to invest in sealed-source management and user-friendly shielding solutions, while payers increasingly emphasize value-based outcomes that link procedural choice to patient-reported metrics and long-term toxicity profiles. Simultaneously, supply-chain resilience and localization of component sourcing have grown in importance, catalyzing strategies such as dual-sourcing and regional manufacturing partnerships. These transformative shifts are interdependent: advances in device design influence care-pathway integration, regulatory priorities drive design validation, and reimbursement frameworks affect which innovations achieve scale.

Assessing the cumulative impact of United States tariffs in 2025 on brachytherapy device supply chains, clinical access pathways, and procurement resilience strategies

The introduction of tariffs in 2025 affecting medical device components and radioactive sources has created a new layer of operational and strategic complexity for manufacturers, providers, and distributors. Procurement teams are reassessing supplier relationships, lead-time buffers, and inventory strategies to absorb potential cost fluctuations while preserving treatment continuity. Reaction pathways include renegotiation of long-term supply agreements, reconfiguration of logistic routing, and closer collaboration with regional suppliers to mitigate exposure to cross-border cost adjustments.

Clinically, hospitals and specialized cancer centers are implementing inventory governance and prioritization protocols to ensure uninterrupted access for high-acuity cases. Manufacturers are accelerating efforts to qualify alternative component sources and to validate equivalence across manufacturing sites so that production can pivot without compromising quality assurance processes. In parallel, commercial teams are recalibrating contracting approaches and service bundles to preserve total-cost-of-care propositions for customers, emphasizing integrated training, maintenance, and source management support to maintain clinical partners' confidence amid tariff-driven uncertainty.

Key segmentation insights synthesizing product types, clinical applications, radioactive source varieties, and end-user settings to inform targeted clinical and commercial strategies

A segmentation-led perspective reveals differentiated dynamics that inform product development and go-to-market decisions. When evaluating by product type-High Dose Rate, Low Dose Rate, and Pulsed Dose Rate-High Dose Rate systems continue to attract investment for their procedural efficiency and versatility across multiple clinical indications, while Low Dose Rate offerings maintain relevance for certain ocular and prostate protocols where prolonged source residency aligns with established practice. Pulsed Dose Rate occupies a niche role where radiobiological rationale and patient-specific considerations favor intermittent dose delivery.

Clinical application segmentation across Breast Cancer, Cervical Cancer, Ocular Tumors, and Prostate Cancer highlights where clinical evidence, guideline endorsement, and multidisciplinary team adoption converge to drive demand. For instance, prostate workflows often require integrated imaging and precision applicators, whereas ocular treatments prioritize microsource handling and specialized collimation. Source type distinctions-Cs-137, I-125, Ir-192, and Pd-103-carry implications for handling, half-life logistics, regulatory licensing, and dosimetric planning; institutions weigh these attributes when aligning procurement with clinical caseload profiles. End-user segmentation, covering Ambulatory Surgical Centres, Cancer Research Centers, and Hospitals, signals divergent purchasing models and operational constraints: ambulatory centers seek compact, efficient systems that support high throughput, research centers prioritize modularity and assay capability for investigational protocols, and hospitals require robust service agreements and integration with existing radiotherapy suites. These segmentation lenses should drive product roadmaps, clinical training investments, and commercial articulation of value propositions to ensure alignment with specific user needs and procedural infrastructures.

Regional priorities and differentiated growth enablers across Americas, Europe, Middle East & Africa, and Asia-Pacific that influence clinical adoption and procurement dynamics

Regional dynamics continue to dictate adoption velocity and deployment strategies across distinct geographies. In the Americas, advanced clinical infrastructure and established reimbursement pathways facilitate early adoption of iterative device innovations, although cost containment pressures and procurement cycles require compelling total-cost-of-care narratives. Europe, Middle East & Africa present a heterogeneous landscape in which regulatory harmonization, regional procurement consortia, and variable clinical capacity shape differentiated entry strategies; partnerships with regional distributors and locally tailored service models often determine longer-term presence. Asia-Pacific is characterized by rapid capacity expansion in tertiary oncology centers, aggressive adoption of minimally invasive procedures, and increasing local manufacturing capabilities, which together create both competitive challenges and collaboration opportunities for foreign developers.

Each region demands nuanced approaches to training, regulatory submissions, and post-market surveillance. Stakeholder engagement must account for variations in clinical guidelines, operator skill levels, and facility layouts, and manufacturers should prioritize modular solutions that can be customized to local procedural and infrastructure requirements. Strategic alliances with regional clinical leaders and investment in scalable training programs are essential to transform early interest into consistent clinical utilization across these diverse markets.

Competitive and corporate insights into leading manufacturers, innovator partnerships, intellectual property positioning, and service-oriented propositions shaping sector dynamics

Competitive dynamics in the brachytherapy sector reflect a blend of legacy manufacturers, emerging device innovators, and specialized service providers. Established firms differentiate on comprehensive service networks, regulatory track records, and integrated product suites that bundle applicators, sources, and planning software. New entrants seek to displace incumbents through focused innovation in user ergonomics, source delivery mechanisms, and cloud-enabled treatment planning that reduces on-site computational requirements.

Strategic corporate behaviors include alliance formation with imaging and oncology software vendors to deliver end-to-end treatment pathways, investment in intellectual property around applicator geometries and source encapsulation, and expansion of value-added services such as remote training, maintenance-as-a-service, and inventory management. Observed commercial tactics emphasize proof-of-concept programs with leading clinical centers to accelerate peer-reviewed evidence generation, and tiered pricing models that reflect the heterogeneity of end users from high-volume ambulatory surgery centers to complex tertiary hospitals. These approaches collectively shape competitive positioning and influence purchasing discussions with health system procurement committees.

Actionable recommendations for industry leaders to align research and development, commercial models, supply resilience, and stakeholder engagement with evolving clinical and policy demands

Industry leaders should prioritize initiatives that enhance clinical value while strengthening operational resilience. First, aligning R&D investments to demonstrable clinical outcomes and user ergonomics will accelerate clinician adoption; this includes prioritizing imaging integration, applicator modularity, and simplified source handling processes that reduce procedure time and variability. Second, companies should build robust supply-chain diversification plans that include validated alternative suppliers and regional production options to mitigate tariff and logistics volatility, coupled with transparent inventory governance tools for provider partners.

Third, commercial strategies should emphasize bundled service offerings-training, maintenance, and source management-to preserve predictable lifecycle economics for customers. Fourth, establishing formal partnerships with leading clinical centers to drive prospective evidence generation and guideline inclusion will create durable clinical preference. Finally, engaging proactively with regulators and payers to articulate safety, efficacy, and value propositions can smooth adoption pathways and align reimbursement structures with long-term patient and system benefits. Implementing these recommendations will require cross-functional commitment and measurable KPIs linked to clinical adoption and service performance.

Transparent research methodology detailing data sources, qualitative and quantitative analytical approaches, stakeholder interviews, and validation steps ensuring rigor and reproducibility

The analysis underpinning this summary was developed through a combination of primary stakeholder engagement, technical literature synthesis, and triangulation of publicly available regulatory and clinical guidance documents. Primary inputs included structured interviews with practicing radiation oncologists, medical physicists, procurement officers, and clinical engineers to validate real-world workflows, device handling pain points, and procurement rationales. Secondary inputs focused on peer-reviewed clinical outcomes literature, device safety notices, and procedural guidelines to map clinical indications to device capabilities.

Analytical methods included cross-segmentation synthesis to identify where product attributes align with clinical use-cases, scenario analysis to explore supply-chain shocks and tariff impacts, and qualitative benchmarking across competing value propositions. Validation steps comprised expert review sessions with practicing clinicians and biomedical engineers to confirm technical accuracy and applicability of recommendations. Wherever possible, assertions were corroborated by multiple independent sources to ensure robustness and relevance to decision-makers across clinical, procurement, and corporate strategy functions.

Concise conclusion synthesizing strategic implications, operational risks, and priority opportunities for clinical, commercial, and regulatory stakeholders

In conclusion, brachytherapy devices occupy a strategic niche in oncology care where precision, organ preservation, and procedural efficiency intersect. The combination of technological refinements in delivery systems, evolving regulatory expectations, and payer emphasis on value-based outcomes creates both opportunity and complexity for device developers and clinical adopters. Supply-chain pressures and tariff-induced cost dynamics require proactive mitigation strategies, while regionally tailored approaches to training and service delivery will determine the pace and quality of adoption across diverse healthcare systems.

Stakeholders that successfully integrate clinical evidence generation, modular product design, and resilient commercial models will be best positioned to capture long-term clinical partnerships. By focusing on interoperability with existing oncology workflows, enhancing user-centric design, and investing in collaborative evidence programs with leading clinical centers, organizations can translate innovation into measurable clinical and operational value. The path forward emphasizes pragmatic innovation that addresses daily procedural realities as much as it advances long-term therapeutic goals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of MRI and ultrasound real-time imaging for adaptive brachytherapy treatment planning and delivery
  • 5.2. Adoption of 3D-printed patient-specific brachytherapy applicators to improve dose conformity and reduce setup time
  • 5.3. Development of novel low-dose-rate isotopes like cesium-131 for faster radiation decay and improved patient outcomes
  • 5.4. Introduction of compact high-dose-rate afterloaders enabling outpatient brachytherapy and reduced hospital stays
  • 5.5. Emergence of AI-driven treatment planning software for precise seed placement and reduced procedural risks
  • 5.6. Expansion of MR-guided brachytherapy adoption in emerging markets driven by favorable reimbursement policies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brachytherapy Devices Market, by Product Type

  • 8.1. High Dose Rate
  • 8.2. Low Dose Rate
  • 8.3. Pulsed Dose Rate

9. Brachytherapy Devices Market, by Application

  • 9.1. Breast Cancer
  • 9.2. Cervical Cancer
  • 9.3. Ocular Tumors
  • 9.4. Prostate Cancer

10. Brachytherapy Devices Market, by Source Type

  • 10.1. Cs-137
  • 10.2. I-125
  • 10.3. Ir-192
  • 10.4. Pd-103

11. Brachytherapy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centres
  • 11.2. Cancer Research Centers
  • 11.3. Hospitals

12. Brachytherapy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brachytherapy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brachytherapy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Varian Medical Systems, Inc.
    • 15.3.2. Elekta AB (publ)
    • 15.3.3. Ion Beam Applications S.A.
    • 15.3.4. C. R. Bard, Inc.
    • 15.3.5. Eckert & Ziegler AG
    • 15.3.6. Theragenics Corporation
    • 15.3.7. IsoRay, Inc.
    • 15.3.8. Proxima Therapeutics, Inc.
    • 15.3.9. Shanghai Atom High-Tech Co., Ltd.
    • 15.3.10. Best Medical International, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRACHYTHERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BRACHYTHERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 338. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 339. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. JAPAN BRACHYTHERAPY DEVICES MARK